Amy N. Luckenbaugh, MD, FACS

Assistant Professor
Department of Urology
Division of Urologic Oncology

Medical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer

Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as the chair of Women in Urologic Oncology, and the secretary for the Society of Women in Urology, and through her research aims to mitigate variation in healthcare delivery.

Dr. Luckenbaugh Faculty Bio

About Your Prostate Cancer Diagnosis

Active Clinical Trials

FKD Therapies/Instiladrin

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Learn more about this trial

PI: Amy Luckenbaugh, MD

Female Cystectomy

Sexual Function in Women after Radical Cystectomy.

PI: Amy Luckenbaugh, MD

Bond 003

To evaluate the activity of intravesical (IVE) administration of CG0070 in patients with tissue pathology confirmed non-muscular invasive bladder cancer (NMIBC) who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either carcinoma in situ with or without Ta/T1 disease

Learn more about this trial

PI: Amy Luckenbaugh, MD